Entity
  • CLARA - Cancéropôle Lyon Auvergne Rhône-Alpes

    Created in 2003
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    3,126 5,674
  • Activities

  • Entity types

  • Location

    213 Rue de Gerland Bâtiment C, 69007 Lyon, France

    Lyon

    France

  • Employees

    Scale: 2-10

    Estimated: 14

  • SIREN

    337607303
  • Engaged corporates

    49
    12 35
  • Added in Motherbase

    5 years, 7 months ago
Description
  • Value proposition

    The goal of the Cancéropôle (cancer cluster) Lyon Auvergne Rhône-Alpes (CLARA) is to structure and facilitate cancer research in the French Rhône-Alpes Auvergne inter region by bringing together academic, clinical and industrial strengths in order to develop a network with a European dimension.
    CLARA is distinct from the six other French cancéropôles due to its amplitude of funding by local authorities.
    This particular feature confers strong economic objectives, on top of the objectives related to scientific excellence and public health as presented in the French Cancer Plans.
    An important feature of CLARA’s strategy is to promote cancer research applications with clear industrial objectives.

    The CLARA Cancer Research Cluster strives to bringing together researchers, clinicians and industrial partners into a single network, and to pool their efforts on operational research programs with a two-fold objective of quickly transferring knowledge to patient care and developing marketable applications of research findings.

    From the laboratory to industrial production, CLARA constitutes a missing link by promoting the industrial transfer and commercial development of an idea.
    Leading a program to support innovative, high-potential projects in the area of health/oncology/biotechnology, called “Proof of Concept”, the Cancéropôle is making a difference, confirming its role as a dynamic actor of economic development.

    Cancer Cluster, Cancer Research Network, Proof of Concept, Academic/clinical and Industrial Partnerships, Oncology Scientific Events, Regulatory Issues related to Clinical Transfer, recherche clinique, vulgarisation scientifique, événement scientifique, financement de projets de recherche, and international

  • Original language

    Sur la base d'une initiative régionale impulsée en 2001, le
    Cancéropôle Lyon Auvergne-Rhône-Alpes est soutenu par les
    pouvoirs publics depuis 2003 dans le cadre des Plans Cancer
    nationaux. Il a pour objectif de développer et valoriser la recherche
    en cancérologie en Auvergne-Rhône-Alpes.

    Le CLARA est un animateur de réseau. Il fédère les acteurs
    académiques, nationaux et internationaux de lutte contre le cancer
    dans un double objectif : le transfert rapide des découvertes vers les
    patients et la valorisation économique de la recherche.
    www.canceropole-clara.com

    Le Cancéropôle est soutenu par la Fondation Innovation et Transitions.

Corporate interactions BETA
Corporate TypeTweets Articles
Pfizer
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Other

18 Mar 2021

3 May 2023



Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

8 Sep 2024


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Other

19 Apr 2021

3 May 2023



Pouss@LYS
Pouss@LYS
Financial Services
Pouss@LYS
Financial Services
Other

31 Aug 2024


Clermont Auvergne Innovation
Clermont Auvergne Innovation
Research, Research Services
Clermont Auvergne Innovation
Research, Research Services
Other

8 Apr 2021

27 Jun 2023



PULSALYS
PULSALYS
Research, Research Services
PULSALYS
Research, Research Services
Other

29 Sep 2021

17 Jul 2024



Eurostat
Eurostat
European Union, Environmental Services
Eurostat
European Union, Environmental Services
Other

20 Mar 2023


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

21 Jan 2022


CNRS
CNRS
Research, Research Services
CNRS
Research, Research Services
Other

30 Jan 2024


Similar entities
Loading...
Loading...
Social network dynamics